FI114968B - Kosmeettinen menetelmä luontaisesti vanhenevan ihon oireiden estämiseksi retinoideilla - Google Patents
Kosmeettinen menetelmä luontaisesti vanhenevan ihon oireiden estämiseksi retinoideilla Download PDFInfo
- Publication number
- FI114968B FI114968B FI900293A FI900293A FI114968B FI 114968 B FI114968 B FI 114968B FI 900293 A FI900293 A FI 900293A FI 900293 A FI900293 A FI 900293A FI 114968 B FI114968 B FI 114968B
- Authority
- FI
- Finland
- Prior art keywords
- skin
- retinoid
- retinoids
- aging
- acid
- Prior art date
Links
- 230000032683 aging Effects 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 12
- 208000024891 symptom Diseases 0.000 title claims description 7
- 239000002537 cosmetic Substances 0.000 title claims description 4
- 229930002330 retinoic acid Natural products 0.000 claims abstract description 15
- 150000004492 retinoid derivatives Chemical class 0.000 claims abstract description 14
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 11
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003937 drug carrier Substances 0.000 claims abstract description 3
- 229960005280 isotretinoin Drugs 0.000 claims abstract description 3
- 229960003471 retinol Drugs 0.000 claims abstract description 3
- 235000020944 retinol Nutrition 0.000 claims abstract description 3
- 239000011607 retinol Substances 0.000 claims abstract description 3
- 229960001727 tretinoin Drugs 0.000 claims description 16
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 10
- -1 tetramethyl-2-naphthalenyl Chemical group 0.000 claims description 7
- 239000005711 Benzoic acid Substances 0.000 claims description 6
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 5
- 235000010233 benzoic acid Nutrition 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- SHGAZHPCJJPHSC-XFYACQKRSA-N isotretinoin Chemical compound OC(=O)/C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-XFYACQKRSA-N 0.000 claims description 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 2
- 235000019445 benzyl alcohol Nutrition 0.000 claims description 2
- 125000006125 ethylsulfonyl group Chemical group 0.000 claims description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 2
- CCQKWSZYTOCEIB-UHFFFAOYSA-N 1,1,4,4-tetramethyl-2,3-dihydronaphthalene Chemical compound C1=CC=C2C(C)(C)CCC(C)(C)C2=C1 CCQKWSZYTOCEIB-UHFFFAOYSA-N 0.000 claims 1
- YRNAHKPMDMVFMV-MBHVDWAISA-N 4-[(1E)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hexa-1,3,5-trienyl]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C YRNAHKPMDMVFMV-MBHVDWAISA-N 0.000 claims 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract description 16
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 45
- 241000699670 Mus sp. Species 0.000 description 23
- 102000008186 Collagen Human genes 0.000 description 13
- 108010035532 Collagen Proteins 0.000 description 13
- 229920001436 collagen Polymers 0.000 description 13
- 239000003981 vehicle Substances 0.000 description 9
- SHGAZHPCJJPHSC-UHFFFAOYSA-N Panrexin Chemical compound OC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 229940002683 retin-a Drugs 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 7
- 206010040954 Skin wrinkling Diseases 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 102000016611 Proteoglycans Human genes 0.000 description 4
- 108010067787 Proteoglycans Proteins 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 230000001744 histochemical effect Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 206010048245 Yellow skin Diseases 0.000 description 2
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000002390 hyperplastic effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000020945 retinal Nutrition 0.000 description 2
- 239000011604 retinal Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 238000004383 yellowing Methods 0.000 description 2
- XAETVFCFSFGPDL-ZLLKFVMWSA-N (2e,4e,6e)-3-methyl-7-(1,1,3,3-tetramethyl-2h-inden-5-yl)octa-2,4,6-trienoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)C1=CC=C2C(C)(C)CC(C)(C)C2=C1 XAETVFCFSFGPDL-ZLLKFVMWSA-N 0.000 description 1
- HGGVUZHIUHCATB-OOUGZNGESA-N (2e,4e,6e)-3-methyl-7-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)octa-2,4,6-trienoic acid Chemical compound CC1(C)CCC(C)(C)C=2C1=CC(C(/C)=C/C=C/C(/C)=C/C(O)=O)=CC=2 HGGVUZHIUHCATB-OOUGZNGESA-N 0.000 description 1
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- FUCBJLFYALIAEU-NTCAYCPXSA-N 4-[(e)-2-(1,1,3,3-tetramethyl-2h-inden-5-yl)prop-1-enyl]benzoic acid Chemical compound C=1C=C(C(CC2(C)C)(C)C)C2=CC=1C(/C)=C/C1=CC=C(C(O)=O)C=C1 FUCBJLFYALIAEU-NTCAYCPXSA-N 0.000 description 1
- UHFICAKXFHFOCN-UHFFFAOYSA-N 6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)naphthalene-2-carboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C=3C=C4C(C)(C)CCC(C4=CC=3)(C)C)=CC=C21 UHFICAKXFHFOCN-UHFFFAOYSA-N 0.000 description 1
- 206010000349 Acanthosis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 150000004508 retinoic acid derivatives Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 150000002266 vitamin A derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Physical Vapour Deposition (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Devices For Indicating Variable Information By Combining Individual Elements (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29911989A | 1989-01-19 | 1989-01-19 | |
US29911989 | 1989-01-19 | ||
CA 588835 CA1335651C (en) | 1989-01-20 | 1989-01-20 | Method for the treatment or prevention of intrinsically aged skin with retinoids |
CA588835 | 1989-01-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI900293A0 FI900293A0 (fi) | 1990-01-18 |
FI114968B true FI114968B (fi) | 2005-02-15 |
Family
ID=25672393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI900293A FI114968B (fi) | 1989-01-19 | 1990-01-18 | Kosmeettinen menetelmä luontaisesti vanhenevan ihon oireiden estämiseksi retinoideilla |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP0815840A3 (ja) |
JP (1) | JP2931349B2 (ja) |
AT (1) | ATE164513T1 (ja) |
AU (1) | AU636595B2 (ja) |
DE (1) | DE69032182T2 (ja) |
DK (1) | DK0379367T3 (ja) |
ES (1) | ES2115590T3 (ja) |
FI (1) | FI114968B (ja) |
GR (1) | GR3026573T3 (ja) |
IL (1) | IL93106A0 (ja) |
MY (1) | MY106263A (ja) |
NO (1) | NO900251L (ja) |
PH (1) | PH27578A (ja) |
PT (1) | PT92905B (ja) |
SG (1) | SG73394A1 (ja) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5051449A (en) * | 1991-02-27 | 1991-09-24 | Kligman Albert M | Treatment of cellulite with retinoids |
FR2674127B1 (fr) * | 1991-03-20 | 1993-06-11 | Oreal | Composition cosmetique pour lutter contre le vieillissement de la peau contenant en association au moins un retinouide et au moins une dialkyl- ou trialkylxanthine. |
WO1995027474A1 (fr) | 1994-04-12 | 1995-10-19 | Kao Corporation | Preparation dermatologique |
WO1996029069A1 (en) * | 1995-03-20 | 1996-09-26 | Allergan | Use of retinoids for the manufacture of a medicament for the treatment of restenosis |
US5837224A (en) * | 1996-01-19 | 1998-11-17 | The Regents Of The University Of Michigan | Method of inhibiting photoaging of skin |
CA2281944C (en) | 1997-02-25 | 2007-05-15 | The Regents Of The University Of Michigan | Methods and compositions for preventing and treating chronological aging in human skin |
EP0992232A4 (en) | 1997-03-11 | 2003-01-02 | Pola Chem Ind Inc | TESTING METHODS OF SKIN CARE AGENTS AND EXTERNAL SKIN CARE PRODUCTS MANUFACTURING METHOD |
US6008254A (en) | 1997-05-09 | 1999-12-28 | Kligman; Douglas E. | Method of treating skin disorders with high-strength tretinoin |
USH2043H1 (en) | 1997-05-23 | 2002-08-06 | The Procter & Gamble Company | Skin care compositions |
DE19806946A1 (de) * | 1998-02-19 | 1999-09-09 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen |
DE19820392A1 (de) * | 1998-05-07 | 1999-11-11 | Beiersdorf Ag | Wirkstoffkombinationen enthaltende Hautpflegemittel |
FR2804323B1 (fr) * | 2000-01-31 | 2006-07-07 | Galderma Res & Dev | Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens |
JP2002047125A (ja) * | 2000-05-26 | 2002-02-12 | Shiseido Co Ltd | 皮脂分泌抑制用皮膚外用剤 |
JP2002284678A (ja) * | 2001-03-23 | 2002-10-03 | Ajinomoto Co Inc | 皮膚外用剤 |
US20050202055A1 (en) | 2004-03-11 | 2005-09-15 | Koichi Shudo, Tokyo, Japan | Anti-wrinkle agent |
EP1978971A4 (en) | 2005-12-30 | 2012-03-28 | Revance Therapeutics Inc | ARGININE HETEROMERS FOR TOPICAL HARVESTING |
US8541467B2 (en) | 2006-08-16 | 2013-09-24 | Action Medicines, S.L. | Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ |
JP5665276B2 (ja) | 2008-02-27 | 2015-02-04 | 花王株式会社 | 皮膚老化予防又は改善剤 |
EP2133066A1 (en) | 2008-06-13 | 2009-12-16 | Antonio Puig, S.A. | Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols. |
EP2376198B1 (en) | 2008-12-22 | 2018-03-28 | Johnson & Johnson Consumer Holdings France | A composition comprising a retinoid and method of treating skin conditions |
WO2017053778A1 (en) | 2015-09-25 | 2017-03-30 | Fuchs Helen Burgwyn | Antibacterial and antifungal compounds |
JP2019509262A (ja) * | 2016-02-03 | 2019-04-04 | ガルデルマ・リサーチ・アンド・デヴェロップメント | 新規二芳香族プロピニル化合物、それらを含む薬学的および化粧用組成物ならびにそれらの使用 |
WO2019064109A1 (en) * | 2017-09-28 | 2019-04-04 | Johnson & Johnson Consumer Inc. | COSMETIC COMPOSITIONS AND METHOD FOR TREATING SKIN |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1466062A (en) * | 1974-04-09 | 1977-03-02 | Knight K | Cosmetic preparations |
FR2479819A1 (fr) * | 1980-04-04 | 1981-10-09 | Fabre Sa Pierre | Le retinoate de zinc, sa preparation et les compositions topiques le contenant |
US4603146A (en) * | 1984-05-16 | 1986-07-29 | Kligman Albert M | Methods for retarding the effects of aging of the skin |
JPS62502546A (ja) * | 1985-04-22 | 1987-10-01 | エイボン プロダクツ インコ−ポレイテツド | しわを減少させる組成物及び方法 |
FR2591105B1 (fr) * | 1985-12-11 | 1989-03-24 | Moet Hennessy Rech | Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide. |
KR950014443B1 (ko) * | 1986-07-16 | 1995-11-28 | 엠. 클리그만 알버트 | 일광손상된 인체피부를 치료하기 위한 레티노이드를 함유하는 조성물 |
ZA879063B (en) * | 1986-12-22 | 1989-04-26 | Hoffmann La Roche | Use of 13-cis retinoic acid |
FR2612775B1 (fr) * | 1987-03-25 | 1991-10-11 | Thorel Jean | Compositions pour la prevention et le traitement de la degenerescence cutanee |
AU610587B2 (en) * | 1987-04-06 | 1991-05-23 | Daltex Medical Sciences, Inc. | Treatment of aged skin with oral 13-cis-retinoic acid |
-
1990
- 1990-01-17 AU AU48573/90A patent/AU636595B2/en not_active Expired
- 1990-01-17 MY MYPI90000083A patent/MY106263A/en unknown
- 1990-01-18 EP EP97201923A patent/EP0815840A3/en not_active Withdrawn
- 1990-01-18 AT AT90300521T patent/ATE164513T1/de not_active IP Right Cessation
- 1990-01-18 DE DE69032182T patent/DE69032182T2/de not_active Expired - Lifetime
- 1990-01-18 NO NO90900251A patent/NO900251L/no unknown
- 1990-01-18 IL IL93106A patent/IL93106A0/xx unknown
- 1990-01-18 EP EP90300521A patent/EP0379367B1/en not_active Expired - Lifetime
- 1990-01-18 FI FI900293A patent/FI114968B/fi active IP Right Grant
- 1990-01-18 SG SG1996005501A patent/SG73394A1/en unknown
- 1990-01-18 DK DK90300521T patent/DK0379367T3/da active
- 1990-01-18 ES ES90300521T patent/ES2115590T3/es not_active Expired - Lifetime
- 1990-01-19 PT PT92905A patent/PT92905B/pt not_active IP Right Cessation
- 1990-01-19 PH PH39910A patent/PH27578A/en unknown
- 1990-01-19 JP JP2008534A patent/JP2931349B2/ja not_active Expired - Lifetime
-
1998
- 1998-04-07 GR GR980400765T patent/GR3026573T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO900251D0 (no) | 1990-01-18 |
JPH02288822A (ja) | 1990-11-28 |
EP0379367A2 (en) | 1990-07-25 |
AU636595B2 (en) | 1993-05-06 |
FI900293A0 (fi) | 1990-01-18 |
SG73394A1 (en) | 2000-06-20 |
DK0379367T3 (da) | 1998-10-19 |
AU4857390A (en) | 1990-07-26 |
JP2931349B2 (ja) | 1999-08-09 |
PH27578A (en) | 1993-08-18 |
EP0379367B1 (en) | 1998-04-01 |
NO900251L (no) | 1990-07-20 |
PT92905A (pt) | 1990-07-31 |
DE69032182T2 (de) | 1998-08-20 |
DE69032182D1 (de) | 1998-05-07 |
EP0815840A3 (en) | 1998-03-04 |
GR3026573T3 (en) | 1998-07-31 |
PT92905B (pt) | 1995-12-29 |
EP0379367A3 (en) | 1991-04-24 |
IL93106A0 (en) | 1990-11-05 |
MY106263A (en) | 1995-04-29 |
ATE164513T1 (de) | 1998-04-15 |
EP0815840A2 (en) | 1998-01-07 |
ES2115590T3 (es) | 1998-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI114968B (fi) | Kosmeettinen menetelmä luontaisesti vanhenevan ihon oireiden estämiseksi retinoideilla | |
US4877805A (en) | Methods for treatment of sundamaged human skin with retinoids | |
US4888342A (en) | Methods for treatment of sundamaged human skin with retinoids | |
US5034228A (en) | Pharmaceutical composition, in particular dermatological or cosmetic, comprising hydrous lipidic lamellar phases or liposomes containing a retinoid or a structural analogue thereof such as a carotenoid | |
AU599135B2 (en) | Methods for treatment of sundamaged human skin with retinoids | |
DE69833651T2 (de) | Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut | |
JP2008156349A (ja) | 加齢の徴候を処置するためのプロビタミンa活性を有する少なくとも1種のカロチノイドとプロビタミンa活性を有さない少なくとも1種のカロチノイドの組合せ物の使用 | |
USRE36068E (en) | Methods for treatment of sundamaged human skin with retinoids | |
CA2179426A1 (fr) | Utilisation de ligands specifiques des recepteurs rxrs | |
DE69934410T2 (de) | Behandlung von akne und lichtbedingter alterung durch kurzzeitbehandlung mit topischen retinoiden | |
DE69719495T2 (de) | Verwendung von inhibitoren der retinsäureaktivität zur behandlung empfindliche r haut und/oder durch uv-strahlung hervorgerufener akuter schädigungen | |
FI100581B (fi) | Retinoidia sisältävän koostumuksen kosmeettinen käyttö striae distensa e -vaurioiden koon pienentämiseksi | |
Personelle et al. | Injection of all-trans retinoic acid for treatment of thin wrinkles | |
CA1335651C (en) | Method for the treatment or prevention of intrinsically aged skin with retinoids | |
RU2197235C1 (ru) | Раствор для лечения заболеваний кожи, способ его получения и способ лечения заболеваний кожи | |
IE83435B1 (en) | Method for the prevention of intrinsically aged skin with retinoids | |
IE920623A1 (en) | Methods for treatment of scarring fibrotic alopecia | |
SE1950416A1 (en) | Cream for treatment of skin injured by the sun | |
Shirley de Campos | AlI Trans Retinoic Acid InjectabIe in the Treatment of Thin Wrinldes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 114968 Country of ref document: FI |